SEARCH

SEARCH BY CITATION

References

  • 1
    Archibald H. D. The Addiction Research Foundation: A Voyage of Discovery. Toronto, ON: Addiction Research Foundation; 1990.
  • 2
    Seeley J. R. Death by liver cirrhosis and the price of beverage alcohol. Can Med Assoc J 1960; 83: 13616.
  • 3
    Popham R. E., Schmidt W., de Lint J. The prevention of alcoholism: epidemiological studies of the effects of government control measures. Br J Addict 1975; 70: 12544.
  • 4
    de Lint J., Schmidt W. The distribution of alcohol consumption in Ontario. Q J Stud Alcohol 1968; 29: 96873.
  • 5
    Popham R. E., Schmidt W. A Decade of Alcoholism Research: A Review of the Activities of the Alcoholism and Drug Addiction Research Foundation of Ontario, 1951–1961. Toronto, ON: University of Toronto Press; 1962.
  • 6
    Bruun K., Edwards G., Lumio M., Mäkelä K., Pan L., Popham R. E. et al. Alcohol Control Policies in Public Health Perspective. Helsinki, Finland: Finnish Foundation for Alcohol Studies; 1975.
  • 7
    Room R. Farewell to a unique institution. Addiction 1999; 94: 178991.
  • 8
    Carlen P. L., Wilkinson D. A. Assessment of neurological dysfunction and recovery in alcoholics: CT scanning and other techniques. Subst Alcohol Actions Misuse 1983; 4: 1917.
  • 9
    Israel Y., Kalant H., Khanna J. M., Orrego H., Phillips M. J., Stewart D. J. Ethanol metabolism, oxygen availability and alcohol induced liver damage. Adv Exp Med Biol 1977; 85A: 34358.
  • 10
    Lê A. D., Poulos C. X., Cappell H. Conditioned tolerance to the hypothermic effect of ethyl alcohol. Science 1979; 206: 110910.
  • 11
    Kalant H., LeBlanc A. E., Gibbins R. J. Tolerance to, and dependence on, some non-opiate psychotropic drugs. Pharmacol Rev 1971; 23: 13591.
  • 12
    Kalant H. Research on tolerance: what can we learn from history? Alcohol Clin Exp Res 1998; 22: 6776.
  • 13
    Israel Y., Kalant H., Orrego H., Khanna J. M., Videla L., Phillips J. M. Experimental alcohol-induced hepatic necrosis: suppression by propylthiouracil. Proc Natl Acad Sci USA 1975; 72: 113741.
  • 14
    Corrigall W. A., Coen K. M. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology 1989; 99: 4738.
  • 15
    Tyndale R. F., Droll K. P., Sellers E. M. Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence. Pharmacogenetics 1997; 7: 3759.
  • 16
    Pianezza M. L., Sellers E. M., Tyndale R. F. Nicotine metabolism defect reduces smoking. Nature 1998; 393: 750.
  • 17
    Howard L. A., Sellers E. M., Tyndale R. F. The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence. Pharmacogenomics 2002; 3: 18599.
  • 18
    Linseman M. A., Harding S. Intracerebroventricular morphine enhances alcohol consumption by rats. Pharmacol Biochem Behav 1990; 36: 4058.
  • 19
    Buczek Y., Tomkins D. M., Higgins G. A., Sellers E. M. Dissociation of serotonergic regulation of anxiety and ethanol self-administration: a study with mCPP. Behav Pharmacol 1994; 5: 47084.
  • 20
    Tomkins D. M., Le A. D., Sellers E. M. Effect of the 5-HT3 antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure. Psychopharmacology 1995; 117: 47985.
  • 21
    Le A. D., Li Z., Funk D., Shram M., Li T. K., Shaham Y. Increased vulnerability to nicotine self-administration and relapse in alcohol-naive offspring of rats selectively bred for high alcohol intake. J Neurosci 2006; 26: 18729.
  • 22
    Little H. J., McKinzie D. L., Setnik B., Shram M. J., Em S. Pharmacotherapy of dependence: improving translation from the bench to the clinic. In: McArthurR. A., BorsiniF., editors. Animal and Translational Models for CNS Drug Discovery, Burlington, MA: Academic Press; 2008, p. 91106.
  • 23
    Wong A. H., Macciardi F., Klempan T., Kawczynski W., Barr C. L., Lakatoo S. et al. Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3eta gene. Mol Psychiatry 2003; 8: 15666.
  • 24
    Stein E. J., da Silveira Filho N. G., Machado D. C., Hipólide D. C., Barlow K., Nobrega J. N. Chronic mild stress induces widespread decreases in thyroid hormone alpha1 receptor mRNA levels in brain—reversal by imipramine. Psychoneuroendocrinology 2009; 34: 2816.
  • 25
    Kaminsky Z. A., Tang T., Wang S. C., Ptak C., Oh G. H., Wong A. H. et al. DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet 2009; 41: 2405.
  • 26
    De Luca V., Souza R. P., Viggiano E., Zai C. C., Shinkai T., Lieberman J. A. et al. MDR1 gene in tardive dyskinesia scale scores: comparison of strategies for quantitative trait haplotype analysis. Schizophr Res 2009; 110: 2001.
  • 27
    De Luca V., Mueller D. J., de Bartolomeis A., Kennedy J. L. Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. Int J Neuropsychopharmacol 2007; 10: 697704.
  • 28
    Lee A. M., Jepson C., Hoffmann E., Epstein L., Hawk L. A., Lerman C. et al. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial. Biol Psychiatry 2007; 62: 63541.
  • 29
    Zack M., Poulos C. Z. A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers. Neuropsychopharmacol 2007; 32: 167886.
  • 30
    Meyer J. H., Ginovart N., Boovariwala A., Sagrati S., Hussey D., Garcia A. et al. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 2006; 63: 120916.
  • 31
    So C. H., Verma V., Alijaniaram M., Cheng R., Rashid A. J., O'Dowd B. F. et al. Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers. Mol Pharmacol 2009; 75: 84354.
  • 32
    El-Ghundi M., O'Dowd B. F., Goerge S. R. Insights into the role of dopamine receptor systems in learning and memory. Annu Rev Neurosci 2007; 18: 3766.
  • 33
    Lee F. J., Xue S., Pei L., Vukusic B., Chéry N., Wang Y. et al. Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 2002; 111: 21930.
  • 34
    Seeman P., Van Tol H. H. Dopamine receptor pharmacology. Trends Pharmacol Sci 1994; 15: 26470.
  • 35
    World Health Assembly (WHA). Resolution 58.26. Public Health Problems Caused by the Harmful Use of Alcohol. Geneva, Switzerland: WHO; 2005.
  • 36
    World Health Assembly (WHA). Resolution 61.13. Strategies to Reduce the Harmful Use of Alcohol. Geneva, Switzerland: WHO; 2008.
  • 37
    Rehm J., Room R., Monteiro M., Gmel G., Graham K., Rehn N. et al. Alcohol as a risk factor for global burden of disease. Eur Addict Res 2003; 9: 15764.
  • 38
    Rehm J., Mathers C., Popova S., Thavorncharoensap M., Teerawattananon Y., Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol use disorders. Lancet 2009; 373: 222333.
  • 39
    Rehm J., Chisholm D., Room R., Lopez A. Alcohol. In: JamisonD. T., BremanJ. G., MeashamA. R., AlleyneG., ClaesonM., EvansD. B. et al., editors. Disease Control Priorities in Developing Countries, Washington, DC: Oxford University Press and World Bank; 2006, p. 887906.
  • 40
    Rehm J., Gnam W., Popova S., Patra J., Sarnocinska-Hart A. Avoidable Cost of Alcohol Abuse in Canada 2002. Ottawa, ON: Health Canada; 2008.
  • 41
    Rehm J., Gnam W., Popova S., Baliunas D., Brochu S., Fischer B. et al. The costs of alcohol, illegal drugs, and tobacco in Canada, 2002. J Stud Alcohol Drugs 2007; 68: 88695.
  • 42
    Chisholm D., Doran C., Shibuya K., Rehm J. Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use. Drug Alcohol Rev 2006; 25: 55365.
  • 43
    Gliksman L., McKenzie D., Single E., Douglas R., Brunet S., Moffatt K. The role of alcohol providers in prevention: an evaluation of a server intervention program. Addiction 1993; 88: 118997.
  • 44
    Gliksman L., Douglas D., Rylett M., Narbonne-Fortin C. Reducing problems through municipal alcohol policies: the Canadian experiment in Ontario. Drugs Educ Prev Policy 1995; 2: 10518.
  • 45
    Shain M., Suurvali H., Boutilier M. Healthier Workers: Health Promotion and Employee Assistance Programs. Lexington, MA: Lexington Books, D.C. Health; 1986.
  • 46
    Wolfe D. A., Jaffe P. G., Crooks C. V. Adolescent Risk Behaviors: Why Teens Experiment and Strategies to Keep Them Safe. New Haven, CT: Yale University Press; 2006.
  • 47
    DeWit D. J., Steep B., Silverman G., Stevens-Lavigne A., Ellis K., Smythe C. et al. Evaluating an in-school drug prevention program for at-risk youth. Alberta J Educ Res 2000; 46: 11733.
  • 48
    Graham K. A Night Out, Not ‘Lights out!’: The Case of Safer Bars. Knowledge to Action: A Knowledge Translation Casebook. Ottawa, ON: Canadian Institutes of Health Research; 2008.
  • 49
    Graham K., Osgood D. W., Zibrowski E., Purcell J., Gliksman L., Leonard K. et al. The effect of the Safer Bars programme on physical aggression in bars: results of a randomized controlled trial. Drug Alcohol Rev 2004; 32: 3141.
  • 50
    Graham K., Bernards S., Osgood D. W., Wells S. Bad nights or bad bars? Multi-level analysis of environmental predictors of aggression in late-night large-capacity bars and clubs. Addiction 2006; 101: 156980.
  • 51
    Graham K., Homel R. Raising the Bar: Preventing Aggression in and around Bars, Pubs and Clubs. Cullompton, Devon, UK: Willan Publishing; 2008.
  • 52
    Sanchez-Craig M. Drink Wise: How to Quit Drinking or Cut down, 2nd edn. Toronto, ON: Addiction Research Foundation; 1996.
  • 53
    Sobell L. C., Sobell M. B., Leo G. I., Agrawal S., Johnson-Young L., Cunningham J. A. Promoting self-change with alcohol abusers: a community-level mail intervention based on natural recovery studies. Alcohol Clin Exp Res 2002; 26: 93648.
  • 54
    Miller W., Rolnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York: Guilford Press; 1991.
  • 55
    Cunningham J. A., Wild T. C., Cordingley J., Van Mierlo T., Humphreys K. A randomized controlled trial of an internet-based intervention for alcohol abusers. Addiction 2009; 104: 202332.
  • 56
    Gliksman L., Rylett M., Douglas R. Aboriginal community alcohol harm reduction policy (ACAHRP) project: a vision for the future. Subst Use Misuse 2007; 42: 185166.
  • 57
    Ogborne A. C., Smart R. G. Reactions to research: the case of the evaluation of the Ontario detoxification system. Br J Addict 1982; 77: 27582.
  • 58
    Ogborne A. C., Braun K., Rush B. R. Developing an integrated information system for specialized addiction treatment agencies. J Behav Health Serv Res 1998; 2511: 1007.
  • 59
    Rush B. R., Martin G., Corea L. M. Monitoring alcohol and drug treatment: what would an optimal system look like? Contemp Drug Probl; in press; 2010.
  • 60
    Rush B. R., Urbanoski K. A. Estimating treatment demand for cannabis-related problems in Canada. Int J Ment Health Addict 2007; 5: 1816.
  • 61
    Rush B. R., Urbanoski K., Bassani D., Castel S., Wild T. C., Strike C. et al. Prevalence of co-occurring mental and substance use disorders in the Canadian population. Can J Psychiatry 2008; 53: 8009.
  • 62
    Rush B. R., Bassani D., Urbanoski K., Castel S. Influence of co-occurring mental and substance use disorders on the prevalence of problem gambling in Canada. Addiction 2008; 103: 184756.
  • 63
    Urbanoski K., Rush B. R., Wild T. C., Bassani D., Castel C. The use of mental health care services by Canadians with co-occurring substance dependence and mental illness. Psychiatr Serv 2007; 58: 9629.
  • 64
    Rush B. R., Koegl C. Prevalence and profile of people with co-occurring mental and substance use disorders within a comprehensive mental health system. Can J Psychiatry 2008; 53: 81021.
  • 65
    Castel S., Rush B. R., Kennedy S., Fulton K. Screening for mental health problems among patients with substance use disorders. A pilot project of the validation of a self-assessment instrument. Can J Psychiatry 2007; 52: 227.
  • 66
    Rush B. R., Fogg B., Nadeau L., Furlong A. On the Integration of Mental Health and Substance Use Services and Systems. Ottawa, ON: Canadian Executive Council on Addictions; 2009.
  • 67
    Room R. Social science research and alcohol policy making. In: RomanP., editor. Alcohol: the Development of Sociological Perspectives on Use and Abuse. New Brunswick, NJ: Rutgers Center of Alcohol Studies; 1991, p. 31135.
  • 68
    Edwards G., Anderson P., Babor T., Casswell S., Ferrence R., Giesbrecht N. et al. Alcohol Policy and the Public Good. New York: Oxford University Press; 1994.
  • 69
    Babor T., Caetano R., Casswell S., Edwards G., Giesbrecht N., Graham K. et al. Alcohol: No Ordinary Commodity. Research and Public Policy. Oxford and London: Oxford University Press; 2003.
  • 70
    Babor T., Caetano R., Casswell S., Edwards G., Giesbrecht N., Graham K. et al. Alcohol, No Ordinary Commodity: Research and Public Policy. 2nd edn. Oxford, UK: Oxford University Press.
  • 71
    Eliany M., Giesbrecht N., Nelson M., Wellman B., Wortley S. Highlights Report: National Alcohol and Other Drugs Survey. Ottawa, ON: Health and Welfare Canada; 1990.
  • 72
    Adlaf E., Begin P., Sawka E. Canadian Addiction Survey (CAS): A National Survey of Canadians' Use of Alcohol and Other Drugs: Prevalence of Use and Related Harms: A Detailed Report. Ottawa, ON: Canadian Centre on Substance Abuse; 2005.
  • 73
    Mäkelä K., Room R., Single E., Sulkunen P., Walsh B., Bunce R. et al. Alcohol, Society and the State, vol. I: A Comparative Study of Alcohol Control. Toronto, ON: Addiction Research Foundation; 1981.
  • 74
    Single E. W., Morgan P., de Lint J. Alcohol, Society and the State, vol. II: the Social History of Control in Seven Countries. Toronto, ON: Addiction Research Foundation; 1981.
  • 75
    Giesbrecht N., Demers A., Ogborne A., Room R., Stoduto G., Lindquist E. Sober Reflections: Commerce, Public Health, and the Evolution of Alcohol Policy in Canada, 1980–2000. Montreal, QC: McGill-Queen's University Press; 2006.
  • 76
    Smith H. W., Popham R. E. Blood alcohol levels in relation to driving. Can Med Assoc J 1951; 65: 3258.
  • 77
    Schmidt W. S., Smart R. G. Alcoholics, drinking and traffic accidents. Q J Stud Alcohol 1959; 20: 63144.
  • 78
    Stoduto G., Dill P., Mann R. E., Wells-Parker E., Toneatto T., Shuggi R. Examining the link between drinking driving and depressed mood. J Stud Alcohol Drugs 2008; 69: 77780.
  • 79
    Mann R. E., Anglin L. Alcohol availability, per capita consumption, and the alcohol-crash problem. In: WilsonR., MannR., editors. Drinking and Driving: Advances in Research and Prevention, New York: Guilford Press; 1990, p. 20525.
  • 80
    Stoduto G., Vingilis E. R., Kapur B. M., Sheu W., McLellan B. A., Liban C. B. Alcohol and drug use among motor vehicle collision victims admitted to a regional trauma unit: demographic, injury, and crash characteristics. Accid Anal Prev 1993; 25: 41120.
  • 81
    Vingilis E. R., Salutin L. A prevention programme for drinking driving. Accid Anal Prev 1980; 12: 26774.
  • 82
    Asbridge M., Mann R. E., Flam-Zalcman R., Stoduto G. The criminalization of impaired driving in Canada: assessing the deterrent impact of Canada's first per se law. J Stud Alcohol 2004; 65: 4509.
  • 83
    Mann R. E., Anglin L., Wilkins K., Vingilis E. R., Macdonald S., Shen W. Rehabilitations for convicted drinking drivers: effects on mortality. J Stud Alcohol 1994; 55: 3724.
  • 84
    Mann R. E., Smart R. G., Stoduto G., Adlaf E. M., Vingilis E. R., Beriness D. et al. The effects of drinking-driving laws: a test of the differential deterrence hypothesis. Addiction 2001; 98: 15316.
  • 85
    Sobell M. B., Sobell L. C. Behavioral Treatment of Alcohol Problems: Individualized Therapy and Controlled Drinking. New York: Plenum Press; 1978.
  • 86
    Sobell L. C., Cunningham J. A., Sobell M. B., Agrawal S., Gavin D. R., Leo G. I. et al. Fostering self-change among problem drinkers: a proactive community intervention. Addict Behav 1996; 21: 81733.
  • 87
    Annis H. M. A cognitive–social learning approach to relapse: pharmacotherapy and relapse prevention counselling. Alcohol Alcohol 1991; 1: 52730.
  • 88
    Annis H. M. Relapse to substance abuse: empirical findings within a cognitive–social learning approach. J Psychoact Drugs 1990; 22: 11724.
  • 89
    Sanchez-Craig M., Davila R., Cooper G. A self-help approach for high-risk drinking: effect of an initial assessment. J Consult Clin Psychol 1996; 64: 694700.
  • 90
    Kuhn T. S. The Structure of Scientific Revolutions. Chicago, IL: University of Chicago Press; 1962.